Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
9.45
-0.71 (-6.99%)
Jun 26, 2026, 3:16 PM EDT - Market open
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $378 million as of June 26, 2026. Its market cap has increased by 552.48% in one year.
Market Cap
378.00M
Enterprise Value
401.42M
1-Year Change
552.48%
Ranking
Category
Stock Price
$9.45
Market Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has decreased from $553.50M to $378.00M, a decrease of -31.71%. That is a compound annual growth rate of -12.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 378.00M | 621.40% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 466.60M |
| Shattuck Labs | 460.85M |
| Forte Biosciences | 453.04M |
| Artiva Biotherapeutics | 452.84M |
| vTv Therapeutics | 443.52M |
| Silence Therapeutics | 432.66M |
| Editas Medicine | 429.69M |
| Sagimet Biosciences | 427.94M |